Loading...
Cumberland Pharmaceuticals Inc.
CPIX•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$3.52
$0.16(4.76%)
Cumberland Pharmaceuticals Inc. (CPIX) Financial Performance & Income Statement Overview
Review Cumberland Pharmaceuticals Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-4.26%
↓ 4.26%
Operating Income Growth
-14.34%
↓ 14.34%
Net Income Growth
-3.19%
↓ 3.19%
Operating Cash Flow Growth
-110.05%
↓ 110.05%
Operating Margin
-7.83%
↓ 7.83%
Gross Margin
77.92%
↑ 77.92%
Net Profit Margin
-7.98%
↓ 7.98%
ROE
-12.77%
↓ 12.77%
ROIC
-7.24%
↓ 7.24%
Cumberland Pharmaceuticals Inc. (CPIX) Income Statement & Financial Overview
Review Cumberland Pharmaceuticals Inc.'s (CPIX) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $10.44M | $9.09M | $9.85M | $8.50M |
| Cost of Revenue | $1.98M | $1.32M | $2.85M | $2.73M |
| Gross Profit | $8.46M | $7.76M | $7.00M | $5.77M |
| Gross Profit Ratio | $0.81 | $0.85 | $0.71 | $0.68 |
| R&D Expenses | $1.29M | $1.31M | $1.06M | $1.16M |
| SG&A Expenses | $7.55M | $7.07M | $7.18M | $6.71M |
| Operating Expenses | $10.30M | $9.46M | $8.24M | $7.87M |
| Total Costs & Expenses | $12.28M | $10.78M | $11.09M | $10.60M |
| Interest Income | $106667.00 | $69190.00 | $61841.00 | $96746.00 |
| Interest Expense | $223261.00 | $137374.00 | $126347.00 | $118526.00 |
| Depreciation & Amortization | $1.78M | $1.40M | $1.42M | $1.44M |
| EBITDA | $46207.00 | $13067.00 | $459783.00 | -$336635.00 |
| EBITDA Ratio | $0.004 | $0.001 | $0.05 | -$0.04 |
| Operating Income | -$1.84M | -$1.69M | -$1.24M | -$2.10M |
| Operating Income Ratio | -$0.18 | -$0.19 | -$0.13 | -$0.25 |
| Other Income/Expenses (Net) | -$116594.00 | $168905.00 | -$64506.00 | -$21780.00 |
| Income Before Tax | -$1.96M | -$1.53M | -$1.09M | -$1.89M |
| Income Before Tax Ratio | -$0.19 | -$0.17 | -$0.11 | -$0.22 |
| Income Tax Expense | -$56996.00 | $11442.00 | $11443.00 | $11442.00 |
| Net Income | -$1.90M | -$1.54M | -$1.09M | -$1.95M |
| Net Income Ratio | -$0.18 | -$0.17 | -$0.11 | -$0.23 |
| EPS | -$0.14 | -$0.11 | -$0.08 | -$0.14 |
| Diluted EPS | -$0.14 | -$0.11 | -$0.08 | -$0.14 |
| Weighted Avg Shares Outstanding | $13.97M | $14.05M | $14.12M | $14.10M |
| Weighted Avg Shares Outstanding (Diluted) | $13.97M | $14.05M | $14.12M | $14.10M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan